Intensity Therapeutics, Inc. (INTS)

Intensity Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	2.59	8.56	1.31	4.54	9.32
Short-Term Investments	-	6.22	-	-	-
Cash & Short-Term Investments	2.59	14.78	1.31	4.54	9.32
Cash Growth	-82.47%	1026.22%	-71.10%	-51.28%	10.99%
Other Receivables	-	-	-	0.05	0.05
Receivables	-	-	-	0.05	0.05
Prepaid Expenses	0.77	0.69	0.06	0.07	0.07
Other Current Assets	-	-	0.08	0.07	0.05
Total Current Assets	3.36	15.46	1.45	4.73	9.48
Property, Plant & Equipment	0.12	0.15	0.14	0.32	0.49
Other Long-Term Assets	1.3	1.68	0.17	0.17	0.18
Total Assets	4.78	17.3	1.76	5.22	10.15
Accounts Payable	1.22	3.05	0.6	0.17	0.22
Accrued Expenses	0.51	0.89	0.33	0.34	0.25
Short-Term Debt	-	-	4.35	2.02	-
Current Portion of Leases	0.03	0.02	0.14	0.18	0.17
Other Current Liabilities	-	-	1.39	1.01	0.71
Total Current Liabilities	1.76	3.96	6.82	3.72	1.35
Long-Term Leases	0.11	0.14	-	0.14	0.33
Other Long-Term Liabilities	-	0.04	0.04	0.04	0.04
Total Liabilities	1.87	4.13	6.86	3.9	1.71
Common Stock	0	0	-	0	0
Additional Paid-In Capital	69.7	63.68	23.56	22.39	21.67
Retained Earnings	-66.78	-50.52	-38.65	-31.07	-23.18
Comprehensive Income & Other	-	-	-	-	-0.05
Total Common Equity	2.92	13.16	-15.1	-8.68	-1.56
Shareholders' Equity	2.92	13.16	-5.1	1.32	8.44
Total Liabilities & Equity	4.78	17.3	1.76	5.22	10.15
Total Debt	0.14	0.16	4.49	2.34	0.5
Net Cash (Debt)	2.45	14.62	-3.18	2.2	8.82
Net Cash Growth	-83.23%	-	-	-75.09%	8.43%
Net Cash Per Share	0.18	1.70	-0.93	0.64	2.59
Filing Date Shares Outstanding	15.18	13.71	3.41	3.41	3.41
Total Common Shares Outstanding	15.12	13.71	3.41	3.41	3.41
Working Capital	1.61	11.51	-5.37	1.01	8.13
Book Value Per Share	0.19	0.96	-4.43	-2.55	-0.46
Tangible Book Value	2.92	13.16	-15.1	-8.68	-1.56
Tangible Book Value Per Share	0.19	0.96	-4.43	-2.55	-0.46

Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q